300573.SZ
300573.SZ
CNE100002DV1
XQYY
Loading chart...

Company Profile

Shenyang Xingqi Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of ophthalmic drugs in the People's Republic of China. The company offers myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory and anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs, intraocular rinsing fluids, pupil dilatant and ciliary muscle paralyzers, anti-fatigue medicines, dry eye treatment medicines, mydriatics and cycloplegia drugs, miotics and anti-glaucoma drugs, and intraoperative intraocular irrigation fluids. It also engages in technology development, technical advice, eye hospital, and research and experimental development activities. Shenyang Xingqi Pharmaceutical Co.,Ltd. was founded in 1977 and is based in Shenyang, the People's Republic of China.

Related stocks

300171.SZ
300171.SZ • China
TOFFLON
15.96 CNY
1.83B USD 1Y +9.2%
1066.HK
1066.HK • China
WEIGAO GROUP
3.31 HKD
1.89B USD 1Y -45.4%
688029.SS
688029.SS • China
MICRO-TECH (NANJING) CO LTD
83.3 CNY
2.34B USD 1Y -15.2%
2276.HK
2276.HK • China
CONANT OPTICAL
35.6 HKD
2.19B USD 1Y -13.4%
688050.SS
688050.SS • China
EYEBRIGHT MEDICAL TECHNOLOGY (B
39.16 CNY
1.13B USD 1Y -46.9%
688289.SS
688289.SS • China
SANSURE BIOTECH INC
17.02 CNY
1.46B USD 1Y -20.3%
300888.SZ
300888.SZ • China
WINNERMEDICAL
31.36 CNY
2.74B USD 1Y -19.2%
1501.HK
1501.HK • China
INT MEDICAL
32.36 HKD
1.16B USD 1Y +4.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
54.6% p.a.
Max Drawdown (5Y)
-68.6%
Sharpe Ratio (5Y)
0.02
Beta Factor
0.20
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (54.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -75.3% in the extended horizon.
ende